The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy

Journal: Nature Medicine

Published: 2017-12-01

DOI: 10.1038/nm.4431

Affiliations: 21

Authors: 34

Go to article
Institutions FC
Faculty / Graduate School of Medicine, Osaka University, Japan 0.37
Department of Cancer Immunotherapy, Osaka University, Japan 0.09
Seichoukai Fuchu Hospital, Japan 0.09
Laboratory of Protein Synthesis and Expression, Osaka University, Japan 0.06
Department of Gastroenterological Surgery, Osaka University Hospital, Japan 0.06
Division of Immuno-Gene and Cell Therapy (Takara Bio), Jichi Medical University, Japan 0.04
Department of Respiratory Medicine, Osaka University Hospital, Japan 0.04
Department of Clinical Immunology, Osaka University Hospital, Japan 0.04
WPI Immunology Frontier Research Center (WPI-IFReC), Osaka University, Japan 0.04
Osaka General Hospital of West Japan Railway Company, Japan 0.03
Osaka City General Hospital (OCGH), Japan 0.03
Faculty / Graduate School of Medicine, OCU, Japan 0.03
Medical Institute of Bioregulation (MIB), Kyushu University, Japan 0.03
Graduate School / School of Medicine, Nagoya University, Japan 0.03
Institute of Medical Science (IMSUT), UTokyo, Japan 0.01
Department of Microbiology and Immunology, Osaka University, Japan 0.01